Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

122
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
122
Gene Therapy00:59

Gene Therapy

27.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.9K
Gene Therapy00:59

Gene Therapy

4.7K
4.7K
Human Genetics01:28

Human Genetics

1.8K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K
Genetic Screens02:46

Genetic Screens

5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian family physician Medecin de famille canadien·2026
Same author

The many meanings of community.

Canadian family physician Medecin de famille canadien·2026
Same author

Preventive health care and the craft of family medicine.

Canadian family physician Medecin de famille canadien·2026
Same author

Canadian family physician Medecin de famille canadien·2026
Same author

"Where do I go from here?" Navigating a lifelong road without a map: the care experiences of hereditary cancer patients.

European journal of human genetics : EJHG·2026
Same author

The person, not just the problem.

Canadian family physician Medecin de famille canadien·2026

Related Experiment Video

Updated: Mar 15, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K

The Gene Messenger Impact Project: An Innovative Genetics Continuing Education Strategy for Primary Care Providers.

June C Carroll1, Roland Grad, Judith E Allanson

  • 1Dr. Carroll: Professor, Sydney G. Frankfort Chair in Family Medicine, Department of Family and Community Medicine, Sinai Health System, University of Toronto, Toronto, Ontario, Canada. Dr. Grad: Associate Professor, McGill University, Herzl Family Practice Centre, Centre Médecine Familiale Herzl, Montréal, Quebec, Canada. Dr. Allanson: Department of Genetics, Children's Hospital of Eastern Ontario, Professor, Department of Paediatrics, University of Ottawa, Ottawa, Canada. Dr. Pluye: Full Professor, FRQS Senior Research Scholar, Department of Family Medicine, McGill University, Montréal, Quebec, Canada. Ms. Permaul: Research Associate, Ray D. Wolfe Department of Family Medicine, Sinai Health System, Toronto, Toronto, Ontario, Canada. Dr. Pimlott: Assistant Professor, University of Toronto, Family Practice Health Centre, Women's College Hospital, Toronto, Ontario, Canada. Dr. Wilson: Professor, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada.

The Journal of Continuing Education in the Health Professions
|September 2, 2016
PubMed
Summary

Family physicians found Gene Messengers (GMs), an e-learning tool, valuable for genomic medicine continuing education. This strategy effectively improves genetics knowledge and referral decisions, enhancing patient care.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.6K

Area of Science:

  • Genomic Medicine
  • Continuing Education
  • Knowledge Translation

Background:

  • Primary care providers (PCPs) are crucial for genomic medicine delivery.
  • The GenetiKit trial showed knowledge translation interventions improve genetics referral decision-making for family physicians (FPs).
  • Gene Messengers (GMs) are evidence-based summaries of new genetic tests with primary care recommendations.

Purpose of the Study:

  • To determine the value of GMs as a continuing education (CE) strategy in genomic medicine for FPs.

Main Methods:

  • A "push" model was used, inviting 19,060 Canadian FPs to participate.
  • Participants received 12 emailed GM topics over 6 months and read them online.
  • An online questionnaire assessed GMs on cognitive impact, relevance, intended use, and expected health benefits.

Main Results:

  • 1,402 FPs participated; 55% rated at least one GM.
  • 73% indicated practice improvement, with genetics referrals highly ranked.
  • Of relevant GMs, 94% would be applied to patients, with 79% expecting health benefits.

Conclusions:

  • FPs found GMs a valuable, novel CE strategy for learning about genetics.
  • This e-learning method is effective for rapid advancements in genomic medicine.
  • GMs can overcome knowledge barriers, facilitating genetic service integration.